Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
The death toll in the Turkey Syria earthquake has passed 21,000, Minnesota Rep. Angie Craig was attacked, and shots to stop bird flu. Here is everything you Need2Know for Friday, February 10, 2023.
Hundreds of thousands of school age students went missing from the public school rolls during the height of the COVID-19 pandemic and have not been accounted for since.
The Manhattan District Attorney’s office has asked owners and landlords to commence eviction proceedings on unlicensed shops that have popped up all over the city following cannabis legalization across New York in 2021.
HIV and AIDS have long had a disproportionate impact on the Black community. In recognition of that stark reality, the U.S. government marked February 7 as National Black HIV/AIDS Awareness Day.
